Current concepts in the management of the rheumatoid hand

Journal of Hand Surgery

Volumn 36, Issue 4, 2011, Pages 736-747

  Chung, Kevin C ^a   Pushman, Allison G ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

medical treatment; outcomes; review; Rheumatoid arthritis; surgery

Indexed keywords

ADALIMUMAB; CORTICOSTEROID DERIVATIVE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; MEPREDNISONE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADRENAL INSUFFICIENCY; ARTHROPLASTY; CARDIOVASCULAR SYMPTOM; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; FINGER MALFORMATION; HAND; HAND MALFORMATION; HAND SURGERY; HUMAN; IRRITABILITY; MEDICAL EDUCATION; MEDICAL PRACTICE; METACARPOPHALANGEAL JOINT; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SIDE EFFECT; SURGEON; SURGICAL TECHNIQUE; TENDON RUPTURE; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; EDUCATION, MEDICAL, CONTINUING; FEMALE; FOLLOW-UP STUDIES; HAND DEFORMITIES, ACQUIRED; HAND STRENGTH; HUMANS; MALE; METACARPOPHALANGEAL JOINT; ORTHOPEDIC PROCEDURES; PAIN MEASUREMENT; PHYSICAL THERAPY MODALITIES; RANGE OF MOTION, ARTICULAR; SEVERITY OF ILLNESS INDEX; TENDON INJURIES; TREATMENT OUTCOME; WRIST JOINT;

EID: 79953792196     PISSN: 03635023     EISSN: 15316564     Source Type: Journal    
DOI: 10.1016/j.jhsa.2011.01.019     Document Type: Review

References (56)

1. Kotsis SV, Chung KC. A qualitative assessment of rheumatoid hand surgery in various regions of the world. J Hand Surg 2005;30A:649-657.
2. Alderman AK, Chung KC, Kim HM, Fox DA, Ubel A. Effectiveness of rheumatoid hand surgery: contrasting perceptions of hand surgeons and rheumatologists. J Hand Surg 2003;28A:3-11. (Pubitemid 36105929)
3. Alderman AK, Arora AS, Kuhn L, Wei Y, Chung KC. An analysis of women's and men's surgical priorities and willingness to have rheumatoid hand surgery. J Hand Surg 2006;31A:1447-1453. (Pubitemid 44767722)
4. Alderman AK, Ubel PA, Kim HM, Fox DA, Chung KC. Surgical management of the rheumatoid hand: consensus and controversy among rheumatologists and hand surgeons. J Rheumatol 2003;30:1464-1472. (Pubitemid 36835440)
5. Michaud K, Messer J, Choi HK, Wolfe F. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis Rheum 2003;48:2750-2762. (Pubitemid 37280602)
6. Chung KC, Burns PB, Wilgis EF, Burke FD, Regan M, Kim HM, et al. A multi-center clinical trial in rheumatoid arthritis patients comparing silicone metacarpophalangeal joint arthroplasty with medical treatment. J Hand Surg 2009;34A:815-823.
7. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-799. (Pubitemid 28225778)
8. de la Mata Llord J, Palacios Carvajal J. Rheumatoid arthritis: are outcomes better with medical or surgical management? Orthopedics 1998;21:1085-1086.
9. Alderman AK, Chung KC, DeMonner S, Spilson SV, Hayward RA. Large area variations in the surgical management of the rheumatoid hand. Surg Forum 2001;LII:479-481.
10. Alderman AK, Chung KC, Demonner S, Spilson SV, Hayward RA. The rheumatoid hand: a predictable disease with unpredictable surgical practice patterns. Arthritis Rheum 2002;47:537-542. (Pubitemid 35291377)
11. Ghattas L, Mascella F, Pomponio G. Hand surgery in rheumatoid arthritis: state of the art and suggestions for research. Rheumatology 2005;44:834-845. (Pubitemid 41511176)
12. Klockars M, Koskela RS, Järvinen E, Kolari PJ, Rossi A. Silica exposure and rheumatoid arthritis: a follow up study of granite workers 1940-81. Br Med J (Clin Res Ed) 1987;294:997-1000.
13. Steenland K, Goldsmith DF. Silica exposure and autoimmune diseases. Am J Ind Med 1995;28:603-608.
14. Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunwald J, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46. (Pubitemid 43122184)
15. Cornelis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A 1998;95:10746-10750.
16. Aho K, Koskenvuo M, Tuominen J, Kaprio J, et al. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986;13:899-902. (Pubitemid 17203922)
17. Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993;32:903-907. (Pubitemid 23301303)
18. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ Chokkolingam AP, Alexander HC, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004;75:330-337. (Pubitemid 38943877)
19. Lee AT, Li W, Liew A, Bombardier C, Weisman M, Massarotti EM, et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun 2005;6:129-133. (Pubitemid 40439538)
20. Stastny P, Fink CW. HLA-Dw4 in adult and juvenile rheumatoid arthritis. Transplant Proc 1977;9:1863-1866. (Pubitemid 8256524)
21. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-1213.
22. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994;56:389-466. (Pubitemid 24242228)
23. Deighton CM, Walker DJ, Griffiths ID, Roberts DF.. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989;36:178-182. (Pubitemid 19218460)
24. Schett G, Stach C, Zwerina J, Voll R, Manger B. How antirheumatic drugs protect joints from damage in rheumatoid arthritis. Arthritis Rheum 2008;58:2936-2948.
25. Matsumoto AK, Bathon JM, Bingham CO. Rheumatoid arthritis treatment. The John Hopkins Arthritis Center. http://www.hopkinsarthritis.org/arthritis-info/ rheumatoid-arthritis/rheum-treat.html. Accessed October 31, 2008.
26. Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf 2007;30:861-881. (Pubitemid 47481442)
27. Gibofsky A. Combination therapy for rheumatoid arthritis in the era of biologicals. HSS J 2006;2:30-41. (Pubitemid 44421778)
28. Lard LR, Visser H, Speyer I, vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-451.
29. Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess 206;10:iii-iv, xi-xiii, 1-229.
30. Nurmohamed MT, Dijkmans BA. Are biologics more effective than classical disease-modifying antirheumatic drugs? Arthritis Res Ther 2008;10:118.
31. Weinblatt ME. Rheumatoid arthritis: more aggressive approach improves outlook. Cleve Clin J Med 2004;71:409-413. (Pubitemid 38821199)
32. Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, et al. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol 2003;30:2563-2571. (Pubitemid 37549331)
33. St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004;50:3432-3443. (Pubitemid 39488667)
34. Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weisman MH, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 2004;50:1051-1065. (Pubitemid 38480815)
35. Taleisnik J, Ruby LK. Arthritis deformity: resection arthroplasty and fusion. In Cooney WP, Linscheid RL, Dobyns JH, eds. The wrist. Vol. 2. St. Louis: Mosby, 1998:920-946.
36. Chamay A, Della Santa D. Radiolunate arthrodesis in rheumatoid wrist (21 cases). Ann Chir Main Memb Super 1991;10:197-206.
37. Borisch N, Haussmann P. Radiolunate arthrodesis in the rheumatoid wrist: a retrospective clinical and radiological longterm follow-up. J Hand Surg 2002;27B:61-72. (Pubitemid 34279503)
38. Lau FH, Chung KC. William Darrach, MD: his life and his contribution to hand surgery. J Hand Surg 2006;31A:1056-1060.
39. Fujita S, Masada K, Takeuchi E, Yasuda M, Komatsubara Y, Hashimoto H. Modified Sauve-Kapandji procedure for disorders of the distal radioulnar joint in patients with rheumatoid arthritis. Surgical technique. J Bone Joint Surg 2006;88A (Suppl 1):24-28.
40. Nalebuff EA. Rheumatoid hand surgery - update. J Hand Surg 1983;8:678-682. (Pubitemid 14240629)
41. Radmer S, Andresen R, Sparmann M. Wrist arthroplasty with a new generation of prostheses in patients with rheumatoid arthritis. J Hand Surg 1999;24A:935-943. (Pubitemid 29449276)
42. Cavaliere CM, Chung KC. A systematic review of total wrist arthroplasty compared with total wrist arthrodesis for rheumatoid arthritis. Plast Reconstr Surg 2008;122:813-825.
43. Cavaliere C, Chung KC. Total wrist arthroplasty and total wrist arthrodesis in rheumatoid arthritis: a decision analysis from the hand surgeons' perspective. J Hand Surg 2008;33A:1744-1755.
44. Cavaliere C, Chung KC. A cost - utility analysis comparing total wrist fusion and total wrist arthroplasty for the rheumatoid wrist. J Hand Surg 2010;35A:379-391.
45. Chung KC, Kotsis SV, Kim HM. A prospective outcomes study of Swanson metacarpophalangeal joint arthroplasty for the rheumatoid hand. J Hand Surg 2004;29A:646-653. (Pubitemid 38916709)
46. Chung KC, Kowalski CP, Myra KH, Kazmers IS. Patient outcomes following Swanson silastic metacarpophalangeal joint arthroplasty in the rheumatoid hand: a systematic overview. J Rheumatol 2000;27:1395-1402. (Pubitemid 30354034)
47. Bass RL, Stern PJ, Nairus JG. High implant fracture incidence with Sutter silicone metacarpophalangeal joint arthroplasty. J Hand Surg 1996;21:813-818. (Pubitemid 26374276)
48. Burgess SD, Kono M, Stern PJ. Results of revision metacarpophalangeal joint surgery in rheumatoid patients following previous silicone arthroplasty. J Hand Surg 2007;32:1506-1512. (Pubitemid 350225623)
49. Tupper JW. The metacarpophalangeal volar plate arthroplasty. J Hand Surg 1989;14A:371-375. (Pubitemid 19092954)
50. Ring D, Simmons BP, Hayes M. Continuous passive motion following metacarpophalangeal joint arthroplasty. J Hand Surg 1998;23A:505-511. (Pubitemid 29098751)
51. Chung KC, Ram AN, Shauver M. Outcomes of pyrolytic carbon arthroplasty for the proximal interphalangeal joint. Plast Reconstr Surg 2009;123:1521-1532.
52. Chung K. Tendon transfers for the rheumatoid arthritis patient. In Chung KC, ed. Operative techniques: hand and wrist surgery. 1st ed. Philadelphia: Saunders/Elsevier, 2007:757-770.
53. Stack HG, Vaughan-Jackson OJ. The zig-zag deformity in the rheumatoid hand. Hand 1971;3:62-67.
54. Chung KC, Kotsis SV, Kim HM, Burke FD, Wilgis EF. Reasons why rheumatoid arthritis patients seek surgical treatment for hand deformities. J Hand Surg 2006;31A:289-294. (Pubitemid 43227282)
55. Souter WA. Planning treatment of the rheumatoid hand. Hand 1979;11:3-16. (Pubitemid 9129335)
56. Thompson JS, Littler JW, Upton J. The spiral oblique retinacular ligament (SORL). J Hand Surg 1978;3A:482-487. (Pubitemid 9230916)